BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 22540861)

  • 21. Foam sclerotherapy--a possible option in therapy of varicose veins.
    Kendler M; Wetzig T; Simon JC
    J Dtsch Dermatol Ges; 2007 Aug; 5(8):648-54. PubMed ID: 17659037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stroke after varicose vein foam injection sclerotherapy.
    Forlee MV; Grouden M; Moore DJ; Shanik G
    J Vasc Surg; 2006 Jan; 43(1):162-4. PubMed ID: 16414404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implication of foam sclerosant inactivation by human whole blood in a laboratory setting.
    Dabbs EB; Dos Santos SJ; Mainsiouw LE; Sheikh AA; Gkantiragas A; Shiangoli I; Watkins MR; Nemchand JL; Whiteley MS
    Phlebology; 2018 Jun; 33(5):338-343. PubMed ID: 28516808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Foam sclerotherapy with Fibrovein (STD) for the treatment of hemorrhoids, using a flexible endoscope.
    Benin P; D'Amico C
    Minerva Chir; 2007 Aug; 62(4):235-40. PubMed ID: 17641583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultrasound-guided foam sclerotherapy for the treatment of varicose veins.
    Darke SG; Baker SJ
    Br J Surg; 2006 Aug; 93(8):969-74. PubMed ID: 16739097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. European guidelines for sclerotherapy in chronic venous disorders.
    Rabe E; Breu FX; Cavezzi A; Coleridge Smith P; Frullini A; Gillet JL; Guex JJ; Hamel-Desnos C; Kern P; Partsch B; Ramelet AA; Tessari L; Pannier F;
    Phlebology; 2014 Jul; 29(6):338-54. PubMed ID: 23559590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Visual disturbance following sclerotherapy for varicose veins, reticular veins and telangiectasias: a systematic literature review.
    Willenberg T; Smith PC; Shepherd A; Davies AH
    Phlebology; 2013 Apr; 28(3):123-31. PubMed ID: 23761921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. European Consensus Meeting on Foam Sclerotherapy, April, 4-6, 2003, Tegernsee, Germany.
    Breu FX; Guggenbichler S
    Dermatol Surg; 2004 May; 30(5):709-17; discussion 717. PubMed ID: 15099312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of published information on foam sclerotherapy.
    Stücker M; Kobus S; Altmeyer P; Reich-Schupke S
    Dermatol Surg; 2010 Jun; 36 Suppl 2():983-92. PubMed ID: 20590705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Echo-guided compression sclerotherapy using foam: an improvement in the treatment of varicose veins].
    Kockaert MA; de Roos KP; Neumann HA
    Ned Tijdschr Geneeskd; 2006 Aug; 150(32):1758-63. PubMed ID: 16948234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scrutinizing sclerotherapy.
    Bowman WE
    N C Med J; 1996; 57(3):127-8. PubMed ID: 8935354
    [No Abstract]   [Full Text] [Related]  

  • 32. [Injection sclerotherapy for varicosities of the lower limb: 25 years of experience with 115000 injections].
    Bihari I
    Orv Hetil; 2007 Jan; 148(2):51-8. PubMed ID: 17344119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of polidocanol foam administration into rat peripheral veins on pulmonary parenchyma.
    de Moraes Silva MA; Ferreira RG; de Jesus-Silva SG; Cardoso RS; Miranda F
    Phlebology; 2018 Mar; 33(2):122-127. PubMed ID: 28092205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Phlebosclerosing treatment of lower extremity varicosity using the 'foam-form' technique].
    Bogachev VIu; Zolotukhin IA; Briushkov AIu; Zhuravleva OV
    Angiol Sosud Khir; 2003; 9(2):81-5. PubMed ID: 12811379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The Troyanov-Trendelenburg operation in combination with sclerotherapy as an effective method of outpatient treatment of varicose disease].
    Khubulaeva GG; Sazonov AB; Sazonov AA
    Vestn Khir Im I I Grek; 2007; 166(6):41-3. PubMed ID: 18411740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should foam made with physiologic gases be the standard in sclerotherapy?
    Wong M
    Phlebology; 2015 Oct; 30(9):580-6. PubMed ID: 25392457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Foam sclerotherapy for spouting haemorrhage in patients with varicose veins.
    Hamahata A; Yamaki T; Osada A; Fujisawa D; Sakurai H
    Eur J Vasc Endovasc Surg; 2011 Jun; 41(6):856-8. PubMed ID: 21420881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sclerosants: a comparative review.
    Duffy DM
    Dermatol Surg; 2010 Jun; 36 Suppl 2():1010-25. PubMed ID: 20590708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The French polidocanol study on long-term side effects: a survey covering 3,357 patient years.
    Guex JJ; Schliephake DE; Otto J; Mako S; Allaert FA
    Dermatol Surg; 2010 Jun; 36 Suppl 2():993-1003. PubMed ID: 20590706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results.
    Hamel-Desnos C; Desnos P; Wollmann JC; Ouvry P; Mako S; Allaert FA
    Dermatol Surg; 2003 Dec; 29(12):1170-5; discussion 1175. PubMed ID: 14725657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.